Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0001209191-21-053379

Director sold 120,592 shares at an average $29.29 ($3,531,820)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
GADICKE ANSBERT Director 2021-08-23 Sale −7,376 $29.11 $214,715 273,545 D
GADICKE ANSBERT Director 2021-08-23 Sale −53,359 $29.11 $1,553,280 7,858,018 I
GADICKE ANSBERT Director 2021-08-24 Sale −7,025 $29.48 $207,097 266,520 D
GADICKE ANSBERT Director 2021-08-24 Sale −50,882 $29.48 $1,500,001 7,807,196 I
GADICKE ANSBERT Director 2021-08-25 Sale −237 $29.09 $6,894 266,283 D
GADICKE ANSBERT Director 2021-08-25 Sale −1,713 $29.09 $49,831 7,805,483 I
Open-market sales · 120,592 sh · avg $29.29 · $3,531,820
Loading xslF345X03/doc4.xml…